Rabeprazole Sodium Market Size, Industry Trends, Share and Forecast 2021-2027
The global rabeprazole sodium market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Rabeprazole is used for the treatment of duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It is a condition where the stomach produces too much acid. Rabeprazole sodium can also be used together with antibiotics such as amoxicillin, clarithromycin for the treatment of ulcers that are caused by the H. pylori bacteria. Additionally, it is a type of proton pump inhibitor (PPI) that limits the acid that is produced by the stomach. Increasing demand for proton pump inhibitors are primarily contri buting to the growth of the market.
Other major factor driving the
growth of the global rabeprazole sodium market is the growing prevalence of
gastroesophageal reflux disease (GERD) and ulcers during the forecast period.
According to the National Center for Biotechnology Information, GERD is one of
the most common gastrointestinal disorders which has a prevalence of
approximately 20% of adults in the US. Hence, the growing prevalence of this
disease is driving the growth of the market. However, side effects such as sore
throat, headaches, gas, and diarrhea are expected to hamper the growth of the
market.
To Request a Sample of our Report on Rabeprazole Sodium
Market: https://www.omrglobal.com/request-sample/rabeprazole-sodium-market
Some major players in the market include Pfizer Inc.,
Novartis International AG (Sandoz Inc.), and Teva Pharmaceutical Industries
Ltd., among others. The market players are contributing significantly to the
growth of the market by the adoption of various strategies including mergers
& acquisitions, geographical expansion, partnerships and collaborations,
and new product launches, to stay competitive in the market. For instance, in
November 2021, Woodward Pharma Services LLC has acquired AcipHex (rabeprazole
sodium) from Eisai Co., Ltd.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
• Segment
Covered-
·
By Type
·
By Application
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape-Pfizer Inc.,
Novartis International AG (Sandoz Inc.), and Teva Pharmaceutical Industries
Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Rabeprazole Sodium Market is Available at: https://www.omrglobal.com/industry-reports/rabeprazole-sodium-market
Global Rabeprazole Sodium Market Report by Segment
By Type
• Rabeprazole
Sodium Monohydrate
• Rabeprazole
Sodium Crystalline
By Application
• Gastroesophageal
Reflux Disease Treatment
• Duodenal
Ulcer Treatment
• Others
Global Rabeprazole Sodium Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries
are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment